New stroke clot removal technique could boost recovery rates
NCT ID NCT02523261
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares two ways to remove large blood clots from the brain during a stroke: direct aspiration (ADAPT) and using a stent retriever. About 381 adults with stroke caused by a blocked artery in the front part of the brain took part. The goal is to see which method clears the blockage more completely and safely, potentially improving patients' recovery and reducing long-term disability.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
direct aspiration procedure (ADAPT) and stent retriever procedure
What this could lead to
If ADAPT proves superior, it could become the preferred first-line technique for removing large clots in stroke patients, leading to better recovery and less disability.
What could go wrong
This is a completed study, but results may not apply to all stroke types or settings. The techniques are invasive and carry risks like vessel damage or bleeding.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU Dupuytren
Limoges, France
-
CHU Hôpital Gui de Chaulac
Montpellier, France
-
CHU Pellegrin
Bordeaux, France
-
Fondation Ophtalmologique Adolphe de Rothschild
Paris, 75019, France
-
Hospices Civils de Lyon
Bron, France
-
Hôpital Foch
Suresnes, France
-
Hôpital Guillaume et René LAENNEC
Nantes, France
-
Hôpital Neurologique
Nancy, France